Rohto lifts its 2030 sales target to ¥444bn but trims the margin goal
Rohto Pharmaceutical lifted its 2030 sales target to ¥444.0bn from ¥415.0bn while lowering the margin goal to 12.8% from 13%, and set 2031 targets including a 40% dividend payout ratio.